Skip to main content
  • About Us
  • Investors
  • Careers
  • Contact Us
Choose your market:
United States
  • Global / English
  • Albania / Gjuha shqipe
  • Algeria / Français
  • Argentina / Español
  • Australia / English
  • Austria / Deutsch
  • Bahrain / English
  • Belgium / English
  • Bolivia / Español
  • Bosnia-Herzegovina / BS
  • Bosnia-Herzegovina / EN
  • Brazil / Português
  • Bulgaria / Български
  • Canada / English
  • Canada / Français
  • Chile / Español
  • China / 简体中文
  • China / English
  • Colombia / Español
  • Costa Rica / Español
  • Croatia / Hrvatski jezik
  • Croatia / English
  • Cyprus / English
  • Czech Republic / český
  • Denmark / Dansk
  • Denmark / English
  • Dominican Republic / ES
  • Ecuador / Español
  • Egypt / English
  • El Salvador / Español
  • France / Français
  • Germany / Deutsch
  • Ghana / English
  • Guatemala / Español
  • Hong Kong SAR China / English
  • Hungary / Magyar nyelv
  • India / English
  • Indonesia / English
  • Iraq / English
  • Ireland / English
  • Israel / Hebrew
  • Italy / Italiano
  • Japan / 日本語
  • Jordan / English
  • Kazakhstan / Pусский
  • Kenya / English
  • Kosovo / Gjuha shqipe
  • Kosovo / Srpski
  • Kuwait / English
  • Lebanon / English
  • Macedonia / Македонски јазик
  • Macedonia / Gjuha shqipe
  • Malaysia / English
  • México / Español
  • Montenegro / Montenegrin
  • Morocco / Français
  • Mozambique / Portuguese
  • Netherlands / Nederlands
  • Netherlands / English
  • New Zealand / English
  • Nigeria / English
  • Norway / Norsk
  • Pakistan / English
  • Panama / Español
  • Peru / Español
  • Philippines / English
  • Poland / Polski
  • Portugal / Português
  • Puerto Rico / English
  • Qatar / English
  • Romania / Română
  • Romania / English
  • Russia / Pусский
  • Saudi Arabia / English
  • Serbia / Srpski
  • Singapore / English
  • Slovakia / Slovenský
  • Slovenia / Slovenščina
  • Slovenia / English
  • South Africa / English
  • South Korea / 한국어
  • Spain / Español
  • Sweden / Svenska
  • Switzerland / English
  • Switzerland / Deutsch
  • Taiwan / English
  • Tanzania / English
  • Thailand / English
  • Tunisia / Français
  • Türkiye / Türkçe
  • UAE / English
  • Uganda / English
  • Ukraine / Українська мова
  • Ukraine / English
  • United Kingdom / English
  • United States / English
  • Venezuela / Español
  • Vietnam / English
  • Zambia / English
  • News & Events
    • All
    • News & Polls
    • Events
    • Webinars
    • Newsletter
  • Innovation & Knowledge
    • All
    • Media & Brand Communication
    • Consumer & Shopper
    • Customer Experience
    • Society
    • New Services
  • Our Solutions
    • All
  • Ipsos.digital platform
  • ESG
  • About us
    • Our history
    • Who we are
    • Key figures
    • Management
    • Values
    • Taking responsibility
    • The Path to Insights
    • Privacy & Data Collection
    • Online Data Quality Matters
    • Ipsos in the world
    • Media Resources
    • ISO Certification
  • Investors
  • Careers
    • Why Work at Ipsos
    • Opportunities at Ipsos
    • Professionals
    • Early Careers
    • Search Current Opportunities
    • The Path to Insights
  • Contact Us
  • Ipsos
  • Search

Search

Sort by Date Relevance
We found 1789 results matching with your query. Refine by
  • Society

    The Patient Perspective: Evaluating Time and Treatment While Living with Metastatic Breast Cancer

    The results of this research demonstrate the time-burden on ER+, HER2- mBC patients and their loved ones when going to receive care and the potential difficulty of care when an IM injection is part of their treatment plan.

    3 April 2024
  • WELLNESS 2024

    How AI, new drugs, and your DNA will help us live better for longer

    What wellness — physical, mental, and otherwise — looks like matters for all of us, as individuals and as consumers. Matt Carmichael, editor of What the Future, looks at what the future could hold.

    14 March 2024
  • WELLNESS 2024

    Shifts: Three forces that will shape the future of wellness

    Ipsos Strategy3’s Trevor Sudano looks at the forces that could transform health and wealth in America, from rising temperatures to rising medical bills.

    14 March 2024
  • Society

    Americans’ descriptions of AI are getting more negative

    There’s been a jump in the number of Americans who use negative words to describe AI, compared to the same time last year, according to the Ipsos Consumer Tracker

    13 March 2024
  • Society

    Apathy vs. frenzy in the general election is the difference between Biden facing Haley instead of Trump. Each candidate's brand can explain why

    New Ipsos analysis leverages the Ipsos Brand Success framework to understand how a Trump vs. Biden and Haley vs. Biden match-up could dramatically change the electorate and stakes come November

    4 March 2024
  • New Services

    Truth, Beauty, and Justice: AI in 2024

    Revisit our recorded discussion to hear more about the three necessary domains for evaluating AI - Truth (accuracy), Beauty (fertility), and Justice (fairness) - and the implications of each from the perspectives of our guest panelists.

    27 February 2024
  • Society

    [WEBINAR] Loving or Loathing: Understanding Affluents’ Relationship with Luxury

    With studies running in 50 markets around the world, we are able to offer an unparalleled understanding of how Affluents think and act – insights critical for all marketers hoping to increase share of wallet among the wealthiest consumers.

    22 February 2024
  • Society

    ASCO Annual Meeting 2024

    Are you planning to be at ASCO 2024? Don’t mistake conference buzz for oncologist engagement!

    22 February 2024
  • Society

    Understanding Patients with Metastatic Breast Cancer – A Preference for Oral Treatments

    Research conducted by Ipsos in collaboration with Living Beyond Breast Cancer and funded by Eli Lilly and Company explores the time commitment and treatment preferences among women living with ER+, HER2- metastatic breast cancer

    21 February 2024
  • Society

    LinkedIn Sales Solutions Deep Sales Study

    A new study LinkedIn Sales Solutions partnered with Ipsos on shows sellers who embrace the deep sales approach are more likely to exceed their quota

    21 February 2024
Pagination
  • First page 1
  • Page 10 10
  • Previous page <
  • Current page 16
  • Next page >
  • Page 20 20
  • Page 100 100
  • Last page 179

Refine by

REFINE YOUR SEARCH FOR KEY WORD

  • News & Events
  • Innovation & Knowledge
    • Consumer & Shopper
    • Corporate
    • Customer Experience
    • Entertainment
    • Media & Brand Communication
    • New Services
    • Society
  • OUR SOLUTIONS
    • Capabilities
    • Consumers & Brands
    • Customers & Employees
  • Citizens
  • Consumers & Brands
  • Capabilities
  • Doctors & Patients
  • Customers & Employees
  • About us
  • Contact Us
  • Press
  • Investors
  • Careers
© 2016 - 2025 Ipsos All Rights Reserved
  • Legal Mentions
  • Privacy & Data Protection
  • Cookie Policy
  • Our Alert System